financetom
Business
financetom
/
Business
/
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading
Mar 27, 2024 8:32 AM

11:11 AM EDT, 03/27/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending slightly higher late Wednesday morning, rising 0.18% to 1,370.27 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by 3D printer company voxeljet (VJET) and semiconductor company Sequans Communications ( SQNS ) , which rose 5.1% and 3.1%, respectively. They were followed by biopharmaceutical companies Calliditas Therapeutics ( CALT ) and Genfit ( GNFT ) , which increased 2.7% and 2.6%, respectively.

The decliners from continental Europe were led by biotech firms Biophytis ( BPTS ) and Evaxion Biotech ( EVAX ) , which fell 10% and 4.2%, respectively. They were followed by medical device maker EDAP TMS ( EDAP ) and pharmaceutical company Novo Nordisk ( NVO ) , which dropped 4.1% and 1.3%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company TC Biopharm ( TCBP ) and biotech firm Trinity Biotech ( TRIB ) , which rose 4.9% and 4.2%, respectively. They were followed by biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) and pharmaceutical company Silence Therapeutics ( SLN ) , which were up 3% and 2.6%, respectively.

The decliners from the UK and Ireland were led by cruise line operator Carnival (CUK) and financial services company HSBC ( HSBC ) , which were down 1.8% and 1.5% respectively. They were followed by biotech firm Autolus Therapeutics ( AUTL ) and biopharmaceutical company NuCana ( NCNA ) , which lost 1.2% and 1.1% respectively.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CGI's Fiscal Q4 Adjusted Earnings, Revenue Rise
CGI's Fiscal Q4 Adjusted Earnings, Revenue Rise
Nov 5, 2025
08:03 AM EST, 11/05/2025 (MT Newswires) -- CGI (GIB) reported fiscal Q4 adjusted earnings Wednesday of 2.13 Canadian dollars ($1.51) per diluted share, up from CA$1.92 a year earlier. Analysts polled by FactSet expected CA$2.09. Revenue for the quarter ended Sept. 30 was CA$4.01 billion, up from CA$3.66 billion a year earlier. Analysts surveyed by FactSet expected CA$4.02 billion. ...
LendingClub Announces $100 Million Common Stock Repurchase and Acquisition Program
LendingClub Announces $100 Million Common Stock Repurchase and Acquisition Program
Nov 5, 2025
SAN FRANCISCO, Nov. 5, 2025 /PRNewswire/ -- LendingClub Corporation ( LC ) today announced ahead of its Investor Day in New York, NY, that the company's Board of Directors approved a program to repurchase and acquire up to $100 million of the company's common stock through December 31, 2026.1 LendingClub ( LC ) has transformed its business and financial profile...
Energy infrastructure firm Sempra beats Q3 revenue estimates 
Energy infrastructure firm Sempra beats Q3 revenue estimates 
Nov 5, 2025
Overview * Sempra ( SRE ) Q3 revenue beats estimates, reaching $3.15 bln * Adjusted EPS for Q3 beats consensus at $1.11 * Company reports Q3 adjusted net income of $728 mln, surpassing expectations * Sempra ( SRE ) announces 45% equity sale in Sempra Infrastructure Partners Outlook * Sempra ( SRE ) updates 2025 GAAP EPS guidance to $3.05-$3.45...
ACM Research's Q3 Adjusted Earnings Decline, Revenue Rises; Narrows 2025 Revenue Guidance; Shares Drop Pre-Bell
ACM Research's Q3 Adjusted Earnings Decline, Revenue Rises; Narrows 2025 Revenue Guidance; Shares Drop Pre-Bell
Nov 5, 2025
08:04 AM EST, 11/05/2025 (MT Newswires) -- ACM Research ( ACMR ) reported Q3 adjusted earnings Wednesday of $0.36 per diluted share, compared with $0.63 a year earlier. Analysts surveyed by FactSet expected $0.54. Revenue for the quarter ended Sept. 30 was $269.2 million, compared with $204 million a year earlier. Analysts surveyed by FactSet expected $251.7 million. The company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved